Aminocyclopentane alkenoic acids and esters and pharmaceutical formulations
US4327092A · kind A · utility
17Cited by
4References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 29, 1981 |
| Grant date | Apr 27, 1982 |
| Priority date | — |
| Expiry date | Apr 29, 2001 |
Classification
- Technology area (CPC D)Textiles; Paper
- CPC primaryD01F6/625
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds are described of the formula ##STR1## (and their salts and solvates) in which: X is cis or trans --CH.dbd.CH--; PA0 R.sup.1 is C.sub.1-7 alkyl terminated by --COOR.sup.3 where R.sup.3 is H, C.sub.1-6 alkyl or C.sub.7-10 aralkyl; PA0 Y is a saturated heterocyclic amino group having 5-8 ring members; and PA0 R.sup.2 is substituted or unsubstituted thienylalkyl or furanylalkyl. These compounds inhibit blood platelet aggregation and bronchoconstriction and may be formulated for use as antithrombotic and anti-asthmatic agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.